Month: January 2026

Outcomes of a PBM-Aligned Single-Unit Platelet Transfusion Policy in Severe UGI Bleeding

1. Abstract 1.1. Introduction Platelet transfusion practices in patients with upper gastrointestinal (UGI) bleeding have traditionally varied, with limited consensus on optimal dosing or thresholds especially for severe cases. Our institution implemented a restrictive, single-unit platelet transfusion policy as part of a broader patient blood management (PBM) initiative.

Liver Transplantation and Survival in Hepatocellular Carcinoma and Viral Hepati tis: A 19-Year Nationwide Cohort from Taiwan

1. Abstract 1.1. Background Liver transplantation (LT) is the definitive therapy for end-stage liver disease and hepatocellular carcinoma (HCC). However, in HBV-endemic regions, the allocation-relevant implications of the viral hepatitis status, waiting time, age, and donor type remain in completely defined in real-world transplant systems.